[{"address1": "Tower 11", "address2": "Level 10, Avenue 5, No. 8 Jalan Kerinchi", "city": "Kuala Lumpur", "zip": "59200", "country": "Malaysia", "phone": "60 9 08517 7330", "website": "https://www.cyclacel.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, epigenetics, and mitosis biology in the United States and the United Kingdom. Its lead product, Plogosertib or plogo, is a PLK1 inhibitor, in solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Sing Ee Wong", "age": 43, "title": "Chairman, CEO & President", "yearBorn": 1981, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Cu Seng Kiu", "age": 34, "title": "Executive Director, CFO & Secretary", "yearBorn": 1990, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gill  Christie", "age": 67, "title": "Director of Human Resources", "yearBorn": 1957, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Grace  Kim", "title": "Investor Relations Executive", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.2, "open": 2.1, "dayLow": 1.9501, "dayHigh": 2.2584, "regularMarketPreviousClose": 2.2, "regularMarketOpen": 2.1, "regularMarketDayLow": 1.9501, "regularMarketDayHigh": 2.2584, "payoutRatio": 0.0, "forwardPE": -1.0050251, "volume": 144393, "regularMarketVolume": 144393, "averageVolume": 171909, "averageVolume10days": 178124, "averageDailyVolume10Day": 178124, "bid": 1.96, "ask": 2.13, "bidSize": 1, "askSize": 1, "marketCap": 25917000, "fiftyTwoWeekLow": 1.95, "fiftyTwoWeekHigh": 49.28, "priceToSalesTrailing12Months": 1851.2142, "fiftyDayAverage": 4.1516, "twoHundredDayAverage": 9.3179, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 709274048, "profitMargins": 0.0, "sharesOutstanding": 12958500, "sharesShort": 168464, "sharesShortPriorMonth": 3480, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.0008, "heldPercentInsiders": 0.65597, "heldPercentInstitutions": 0.07083, "shortRatio": 0.45, "shortPercentOfFloat": 0.013300001, "impliedSharesOutstanding": 13665400, "bookValue": 0.015, "priceToBook": 133.33334, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -8347000, "trailingEps": -33.44, "forwardEps": -1.99, "lastSplitFactor": "1:16", "lastSplitDate": 1747008000, "enterpriseToRevenue": 50662.434, "enterpriseToEbitda": -55.939, "52WeekChange": -0.94266057, "SandP52WeekChange": 0.11469197, "lastDividendValue": 2.4, "lastDividendDate": 1745884800, "quoteType": "EQUITY", "currentPrice": 2.0, "recommendationKey": "none", "totalCash": 3450000, "totalCashPerShare": 0.01, "ebitda": -12679500, "totalDebt": 9000, "quickRatio": 5.204, "currentRatio": 5.602, "totalRevenue": 14000, "debtToEquity": 0.294, "revenuePerShare": 0.0, "returnOnAssets": -1.6018, "returnOnEquity": -19.50234, "grossProfits": 14000, "freeCashflow": -13246125, "operatingCashflow": -10754000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -906.0714, "financialCurrency": "USD", "symbol": "CYCC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Cyclacel Pharmaceuticals, Inc.", "regularMarketChangePercent": -9.090911, "regularMarketPrice": 2.0, "messageBoardId": "finmb_125004", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1747438246, "regularMarketTime": 1747425602, "exchange": "NCM", "longName": "Cyclacel Pharmaceuticals, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1079447400000, "postMarketChangePercent": 5.0, "postMarketPrice": 2.1, "postMarketChange": 0.0999999, "regularMarketChange": -0.20000005, "regularMarketDayRange": "1.9501 - 2.2584", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 171909, "fiftyTwoWeekLowChange": 0.049999952, "fiftyTwoWeekLowChangePercent": 0.025641, "fiftyTwoWeekRange": "1.95 - 49.28", "fiftyTwoWeekHighChange": -47.28, "fiftyTwoWeekHighChangePercent": -0.95941556, "fiftyTwoWeekChangePercent": -94.26606, "dividendDate": 1746057600, "earningsTimestamp": 1747284600, "earningsTimestampStart": 1754996340, "earningsTimestampEnd": 1755518400, "earningsCallTimestampStart": 1723667400, "earningsCallTimestampEnd": 1723667400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -33.44, "epsForward": -1.99, "fiftyDayAverageChange": -2.1516, "fiftyDayAverageChangePercent": -0.51825804, "twoHundredDayAverageChange": -7.3178997, "twoHundredDayAverageChangePercent": -0.7853594, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Cyclacel Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-05-17"}]